CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to INCY

topical ruxolitinib

Phase 2
Incyte Corporation (INCY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Feb '27
INCYPhase 2

topical ruxolitinib Phase 2 Est. Readout

topical ruxolitinib
Feb 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Pyoderma Gangrenosum

View Full Landscape
Drug Information

Target Indication

Pyoderma Gangrenosum

Clinical Trial

NCT07783412

Last updated: 10/23/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.